Recent posts and comments

• New Approval for Boston Scientific—Europe Sets the Pace for FDA

  Yesterday we told you that Boston Scientific (NYSE: BSX) had got its new family of advanced pacemakers approved for sale in Europe, but that these were not available... Read more »

• Boston Scientific Picks Up the Pace

  Boston Scientific of Natick, MA, will start selling a new line of advanced pacemakers in the European Union. The company announced today that the devices have received the CE Mark of... Read more »

• Mobile Marketing: Who’s on First, What’s on Second, and I Don’t Know What’s on the Third Screen

  If you still think that e-mail and Internet are things you get on your computer, then you’re probably my age. Or maybe half my age.

  I got a taste of the... Read more »

• Let the Epic Curing Begin: Epix and Curis Earn Milestone Payments

  Two Boston-area biotech companies have reached clinical milestones that will earn them a total of $10.5 million from their industry partners.

  Epix Pharmaceuticals of Lexington, MA, announced today that it has... Read more »

• Take Two Blueberry Jelly Beans and Call Me in the Morning: Cambridge Biotech’s Best and Brightest on Show (or Not)

  I went to the Museum of Science yesterday, to see “Cambridge’s premier companies show-off their latest research and products, revealing what makes them world leaders in science!” At least, that was... Read more »

• Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals

  Concert Pharmaceuticals may have found a way to help established drug substances pack a better punch. By substituting a few normal hydrogen atoms with the heavier form, deuterium, the company believes... Read more »

• Constellation Off to a Stellar $32 Million Start, Helmed (For Now) By Ex Millennium Boss

  Constellation Pharmaceuticals, a new drug-discovery company based in Cambridge, MA, today announced that it has raised $32 million in Series A financing.

  One of the lead investors in the deal is... Read more »

• Ambient Charged Up by $3 Million

  Ambient of Newton, MA, develops technology that makes it possible to use the existing electric power grid as a lightning-fast broadband network. The company today announced that it has secured $3... Read more »

• $25 Million Raised for Bargain Shopping

  Retail Convergence, an e-commerce corporation based in Boston, today announced it has raised $25 Million from a number of investors, including New England Development, Breakaway Ventures, Mugar Enterprises, and General Catalyst.... Read more »

• ZS Genetics Enters Race for Genomics X Prize

  A gang of outsiders just arrived in town. Yesterday, at a conference in San Diego, ZS Genetics announced that it is the seventh team to be accepted into the race for... Read more »

• Resolvyx gets $25 Million in Financing to Turn Fish-Oil Science into New Drugs

  Back in November, David Stipp wrote about how Resolvyx Pharmaceuticals of Bedford, MA, is aiming to turn the science of fish oil into treatments for a host of inflammatory diseases,... Read more »

• Cambria Pharmaceuticals Reaps $5.4M Financing

  Cambria Pharmaceuticals of Woburn, MA, has received $5.4 in a Series A round joined by Biogen Idec New Ventures, CommonAngels, and several individual investors, the company announced today. Cambria aims to... Read more »

• With New Machine, Helicos Brings Personal Genome Sequencing A Step Closer

  In the future, your doctor might map your whole genome as a routine diagnostic test. Helicos BioSciences, a five-year-old biotech company in Cambridge, MA, has set out to make that... Read more »

• Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million

  Last year Alnylam Pharmaceuticals (NASDAQ: ALNY) of Cambridge, MA, joined forces with Isis Therapeutics (NASDAQ: ISIS) in Carlsbad, CA, to form a new affiliate, Regulus Therapeutics. All three... Read more »

• Radius Health is Betting on a Better Treatment for Osteoporosis

  Radius Health, a biotech company in Cambridge, MA, has a lot hanging on its clinical trial of a new treatment for osteoporosis. Two weeks ago all the patients were enrolled in... Read more »

• $50 Million Serono Expansion to Create 100 New Massachusetts Jobs

  The pharmaceutical company EMD Serono today announced that it is investing $50 million in building a new research center in Billerica, MA.

  Construction will begin early next year. When the center... Read more »

• Codon Devices to Engineer Protein Drug for Merrimack Pharmaceuticals

  Two local biotech companies have joined forces to develop a new protein drug. The agreement, between Codon Devices and Merrimack Pharmaceuticals, both of Cambridge, MA, was made public today.

  Merrimack... Read more »

• TouchStone Software Sold for $18 Million

  Phoenix Technologies of Milpitas, CA, said today that it will acquire TouchStone Software, the North Andover, MA-based maker of tools for diagnosing and updating Windows personal computers.  Touchstone stockholders will get... Read more »

• Explosives Detection Company Gets $20 Million

  Reveal Imaging, a Bedford, MA-based maker of explosives detection devices, said Tuesday that it has collected $20.3 million from a group of investors led by BBH Capital Partners III.... Read more »

• New England Private Equity Fundraising Way Up—but Venture Capital Segment Down

  New England’s private equity firms raised nearly $7 billion during the first quarter of 2008, more than twice the amount raised in the same period of 2007. That’s far stronger growth... Read more »